3 Stanley Druckenmiller Recursion Pharmaceuticals Trades
Stanley Druckenmiller acquired 1.39 Million Recursion Pharmaceuticals shares worth $12.2 Million. That's 0.47% of their equity portfolio (27th largest holding). The investor's estimated purchase price is $18.8 Million, resulting in a loss of 35%.
Avg closing price
Price range
Increased shares by 406.5% (+1.11 Million shares)
Q3 2022
Avg closing price
$10.13
Price range
$7.83
-
$13.60
Increased shares by 5.3% (+13.7 Thousand shares)
Q1 2022